Moderna Inc. stock outperforms the market despite the day’s losses

0
24


Actions of Moderna Inc. MRNA,
-0,04%
lost 0.04% to $ 70.52 on Tuesday, in what turned out to be a global trading session for the stock market, with the NASDAQ Composite Index COMP,
-0,29%
drop 0.29% to 11,085.25 and Dow Jones Industrial Average DJIA,
-0,47%
down 0.48% to 27,452.66. The fall in the stock broke a two-day streak in a row. Moderna Inc. closed $ 24.69 below its 52-week high ($ 95.21), which the company hit on July 17.

The title showed a mixed performance against some of its competitors on Tuesday, such as AbbVie Inc. ABBV,
-0,44%
fell 0.45% to $ 86.89 and Amgen Inc. AMGN,
+ 0,51%
rose 0.51% to $ 248.30. Transaction volume (5.3 M) remained 9.0 million below its 50-day average volume of 14.3 M

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.

LEAVE A REPLY

Please enter your comment!
Please enter your name here